InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the full record of transactions filed by Yanez Michelle. Officer active across 1 company, notably Inhibitor Therapeutics, Inc.. In total, 4 disclosures have been published. History available since 5 May 2023. The latest transaction was disclosed on 4 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Yanez Michelle is a declarant associated with Inhibitor Therapeutics, Inc., where she is Director. The record shows 4 filings in total, and the 4 sampled filings run from 2023-05-17 to 2026-08-04, with buy and sell amounts of EUR 0 each and a modal transaction nature listed as Attribution.